Welcome to the CMS National Nursing Home Quality Care Collaborative (NHQCC)
The participation agreement provides an overview of participation in the NHQCC
The IPRO Quality Innovation Network-Quality Improvement Organization (QIN-QIO) Nursing Home Team
looks forward to the continued collaboration with your facility in the CMS National Nursing Home
Quality Care Collaborative over the next 4 year time period. The following information provides
an overview of the expectations involved for participation
- Implement facility-level quality improvement efforts with technical support from the IPRO Nursing Home Team
- Participate in educational learning webinars, collaborative peer-to-peer sharing sessions, and conference calls facilitated by IPRO
- Share and spread best practices with support from the IPRO QIN-QIO
-
Submit and share resident-level data as requested to IPRO QIN-QIO for analysis, reporting and
evaluating QI implementation to support collaborative efforts. No data or information related to
IPRO QIN-QIO's quality improvement project that may implicitly or explicitly identify another
participant will be disclosed.
-
Authorize IPRO to release all provider and de-identified resident-level data submitted by our
organization to CMS or its authorized contractors for quality improvement evaluation purposes.
-
Authorize IPRO to release our facility's name as participant to other affiliated providers (e.g.,
corporate senior leaders) and to other affiliated participants in the quality improvement program.
For more information please visit the IPRO Website at:
The Centers for Medicare and Medicaid Services (CMS) contracts with Quality Improvement
Networks-Quality Improvement Organizations (QIN-QIOs) to perform core functions relating to quality
improvement including, but not limited to, technical assistance, data collection and analysis, quality
review studies and stakeholder engagement activities. Applicable statutory and regulatory authorities
for the QIO program are codified in Sections 1151-1160 of the Social Security Act
(42 USC§§ 1320c-1320c12) and Title 42 of the Code of Federal Regulations.
Under contract to CMS, IPRO serves as the QIN-QIO for the New England states, New York, New Jersey,
Ohio, Delaware, Maryland, and the District of Columbia. In this capacity, we are committed to
protecting the data collected from your facility for healthcare quality improvement projects. The
quality improvement projects that we will work on with your facility are "quality review studies,"
defined in 42 CFR Section 480.101(b) as "assessment[s], conducted by or for a QIO, of a patient care
problem for the purpose of improving patient care through peer analysis, intervention, resolution
of the problem and follow-up." Federal regulations, in 42 CFR Section 480.140, mandate
confidentiality protections for individual patients, practitioners and institutions that participate
in such studies. Accordingly, IPRO QIN-QIO cannot and will not disclose data about participants in
a quality review study to any party other than CMS and/or its authorized contractors.
This material was prepared by the IPROQIN-QIO, a partnership of Healthcentric Advisors, Qlarant and
IPRO, serving as the Medicare Quality Innovation Network-Quality Improvement Organization for
the New England states, NY, NJ, OH, DE, MD, and the District of Columbia; under contract with the
Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and
Human Services. The contents do not necessarily reflect CMS policy. 12SOW.IPRO.Tsk.1.2.A1-5.19.01